First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights.
Autor: | Ramesh, Deepthi, Sarkar, Deblina, Joji, Annu, Singh, Monica, Mohanty, Amaresh K., G. Vijayakumar, Balaji, Chatterjee, Mitali, Sriram, Dharmarajan, Muthuvel, Suresh K., Kannan, Tharanikkarasu |
---|---|
Zdroj: | Archiv der Pharmazie; Apr2022, Vol. 355 Issue 4, p1-23, 23p |
Databáze: | Complementary Index |
Externí odkaz: |